期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 55, 期 11, 页码 5388-5391出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.05517-11
关键词
-
资金
- Wellcome Trust
- NIHR Cambridge Biomedical Research Centre
- Sapprasithiprasong Hospital
A 21-year survey conducted in northeast Thailand of antimicrobial resistance to parenteral antimicrobial drugs used to treat melioidosis identified 24/4,021 (0.6%) patients with one or more isolates resistant to ceftazidime (n = 8), amoxicillin-clavulanic acid (n = 4), or both drugs (n = 12). Two cases were identified at admission, and the remainder were detected a median of 15 days after starting antimicrobial therapy. Resistance to carbapenem drugs was not detected. These findings support the current prescribing recommendations for melioidosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据